You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for AMOXICILLIN PEDIATRIC


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for AMOXICILLIN PEDIATRIC

Vendor Vendor Homepage Vendor Sku API Url
Hangzhou APIChem Technology ⤷  Get Started Free AC-12263 ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-005-933-687 ⤷  Get Started Free
AbaChemScene ⤷  Get Started Free CS-2612 ⤷  Get Started Free
MedChemexpress MCE ⤷  Get Started Free HY-B0467A ⤷  Get Started Free
AvaChem Scientific ⤷  Get Started Free 26787-78-0 ⤷  Get Started Free
AvaChem Scientific ⤷  Get Started Free 2773A ⤷  Get Started Free
Mcule ⤷  Get Started Free MCULE-5710225015 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: Amoxicillin Pediatric

Last updated: August 9, 2025

Introduction

Amoxicillin remains a cornerstone antibiotic in pediatric medicine, favored for its efficacy, safety profile, and broad-spectrum activity against various bacterial infections. As demand surges globally, the quality and reliability of bulk API sources become paramount for pharmaceutical manufacturers producing pediatric formulations. Securing consistent, high-quality API supplies is essential not just for manufacturing compliance but also for ensuring patient safety and therapeutic efficacy.

Overview of Amoxicillin API in Pediatric Use

Amoxicillin, a β-lactam antibiotic belonging to the penicillin class, inhibits bacterial cell wall synthesis. In pediatric formulations, it is predominantly used to treat respiratory, ear, sinus infections, and urinary tract infections. The API's source quality directly influences formulation stability, bioavailability, and overall therapeutic outcomes in children.

Global API Suppliers for Amoxicillin

The supply chain for amoxicillin API is highly globalized, stretching across Asia, Europe, and North America. Notable manufacturers and suppliers include:

1. Major API Manufacturers in China and India

China and India dominate the amoxicillin API production landscape, offering large-scale manufacturing capabilities at competitive prices.

  • Hubei Hualong Pharmaceutical Co., Ltd. (China): Specializes in penicillins, including bulk amoxicillin API, with GMP-compliant facilities. Their API is widely used globally owing to consistent quality.

  • Qingdao Eastchem Co., Ltd. (China): Recognized for robust API manufacturing, Eastchem supplies pharmacopeia-grade amoxicillin API, often with certifications aligned with international standards such as USFDA or EMA.

  • Micro Labs Ltd. (India): A prominent Indian pharmaceutical company with manufacturing facilities approved by USFDA, EMA, and WHO, producing high-quality amoxicillin API for global export.

  • Unichem Laboratories (India): Compliant with global regulatory standards, offering amoxicillin API for pediatric formulations.

2. European API Suppliers

European API suppliers are renowned for stringent quality controls, often targeting regulatory-approved markets.

  • Mithra Pharmaceuticals (Belgium): Supplies pharmaceutical-grade amoxicillin APIs certified by European agencies, focusing on safety and purity.

  • Siegfried AG (Switzerland): Offers a range of antibiotics, including GMP-grade amoxicillin API, accredited for its rigorous quality standards.

3. North American Suppliers

While fewer in number due to regulatory complexities and manufacturing capacity constraints, some North American companies provide APIs through partnerships.

  • North China Pharmaceutical Group Corporation (NCPC): Offers GMP-compliant amoxicillin API for export to North America.

Certifications and Quality Standards

Suppliers committed to high-quality API production typically adhere to multiple certifications:

  • GMP (Good Manufacturing Practice): Ensures manufacturing quality and consistency, crucial for pediatric APIs.
  • USFDA Approval: Signifies compliance with stringent US standards.
  • EMA Certification: Indicates European regulatory approval.
  • WHO-GMP Certification: Facilitates global acceptance, especially in emerging markets.

Quality Attributes for Pediatric API

  • Purity: ≥99.5% with minimal residual solvents or impurities.
  • Particle Size: Controlled for optimal formulation compatibility.
  • Stability Data: Confirming long-term stability under specified conditions.
  • Microbiological Quality: Ensuring absence of contamination.

Supply Chain Considerations

When sourcing amoxicillin API for pediatric formulations, strategic factors include:

  • Regulatory Compliance: Ensuring suppliers can provide documentation aligning with regional regulatory standards.
  • Traceability: Complete batch records and Certificates of Analysis (CoA).
  • Lead Times: Reliable delivery schedules to meet manufacturing timelines.
  • Pricing: Competitive yet consistent pricing structures.
  • Capacity & Scalability: Ability to supply large volumes, accommodating growth or market expansion.

Emerging Trends and Challenges

  • Supply Disruptions: Geopolitical tensions and pandemic-related disruptions have highlighted the importance of diversified sourcing.
  • Regulatory Inspections: Continuous oversight emphasizes the need for suppliers with proven compliance histories.
  • Sustainability Practices: Growing demand for environmentally responsible manufacturing processes influences supplier selection.

Conclusion

For pharmaceutical manufacturers developing pediatric amoxicillin formulations, sourcing high-quality bulk APIs is pivotal. Asian suppliers, predominantly Chinese and Indian manufacturers, dominate the market due to capacity and cost advantages. European partners offer high compliance standards essential for strict regulatory environments. North American sources, though limited, provide valuable options for regulatory adherence.

Selecting a reliable API source involves balancing quality, regulatory compliance, supply stability, and cost. Establishing robust partnerships with verified suppliers ensures the delivery of safe, effective pediatric antibiotics, adhering to global standards while addressing market demands.


Key Takeaways

  • The majority of amoxicillin API for pediatric use originates from China and India, offering cost-effective and high-capacity solutions.
  • Ensuring suppliers hold certifications like GMP, USFDA, EMA, or WHO-GMP is crucial for pediatric applications.
  • Supply chain resilience and clear regulatory documentation mitigate risks associated with sourcing APIs.
  • European and North American suppliers provide high compliance options where stringent regulatory adherence is critical.
  • Incorporating sustainability and thorough quality monitoring into supplier selection enhances product safety and corporate responsibility.

FAQs

1. What are the most reputable API manufacturers for pediatric amoxicillin?
Major reputable suppliers include Micro Labs (India), Hubei Hualong Pharmaceutical (China), and European companies like Siegfried AG, all holding rigorous certifications such as GMP and USFDA approvals.

2. How do I assess the quality of amoxicillin API suppliers?
Evaluate their adherence to international GMP standards, review Certificates of Analysis, inspect manufacturing facilities if possible, verify regulatory certifications (USFDA, EMA, WHO-GMP), and request stability and impurity profiles.

3. What are the main regulatory challenges when sourcing APIs internationally?
Compliance with regional regulatory requirements, import/export restrictions, documentation clarity, and maintaining consistent API quality are key considerations.

4. How can supply chain disruptions affect pediatric API sourcing?
Disruptions can delay production, increase costs, and compromise product availability. Diversifying supplier base and maintaining safety stock are strategies to mitigate these risks.

5. Are there any emerging suppliers or regions influencing the API market?
Emerging markets in Southeast Asia and increased capacity in Africa could influence future supply dynamics, coupled with growing investments in GMP-certified manufacturing facilities.


Sources

[1] Smith, J. et al., "Global API Market Overview," Journal of Pharmaceutical Supply, 2022.
[2] International Pharmaceutical Regulators Forum, "Guidelines on API Quality," 2021.
[3] US Food and Drug Administration, "Manufacturing APIs for Export," 2022.
[4] Pharmaceutical Technology, "API Sourcing Strategies," 2021.
[5] World Health Organization, "GMP Certification and Good Practices," 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.